Molecular Oncology
Volume 2, Issue 3 , Pages 223-232, October 2008

Estradiol–estrogen receptor: A key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells

  • Olga Ch. Kousidou

      Affiliations

    • Laboratory of Biochemistry, Section of Organic Chemistry, Biochemistry and Natural Products, Department of Chemistry, University of Patras, 261 10 Patras, Greece
  • ,
  • Aikaterini Berdiaki

      Affiliations

    • Department of Histology, School of Medicine, University of Crete, Heraklion, Greece
  • ,
  • Dimitris Kletsas

      Affiliations

    • Laboratory of Cell Proliferation and Ageing, Institute of Biology, N.C.S.R. “Demokritos”, 153 10 Athens, Greece
  • ,
  • Alexandros Zafiropoulos

      Affiliations

    • Department of Histology, School of Medicine, University of Crete, Heraklion, Greece
  • ,
  • Achilleas D. Theocharis

      Affiliations

    • Laboratory of Biochemistry, Section of Organic Chemistry, Biochemistry and Natural Products, Department of Chemistry, University of Patras, 261 10 Patras, Greece
  • ,
  • George N. Tzanakakis

      Affiliations

    • Department of Histology, School of Medicine, University of Crete, Heraklion, Greece
  • ,
  • Nikos K. Karamanos

      Affiliations

    • Laboratory of Biochemistry, Section of Organic Chemistry, Biochemistry and Natural Products, Department of Chemistry, University of Patras, 261 10 Patras, Greece
    • Corresponding Author InformationCorresponding author. Tel.: +30 2610 997915; fax: +30 2610 997153.

Received 24 April 2008; received in revised form 5 June 2008; accepted 10 June 2008. published online 07 July 2008.

Abstract 

Estrogens are related with the growth and development of target tissues and play a critical role in breast cancer progression. The effects of estrogens are mediated by the estrogen receptors ERα and ERβ, which are members of the nuclear steroid receptor superfamily. To date, it is not known how these hormones elicit many of their effects on extracellular matrix molecules and how these effects can be connected with ER expression. For this purpose, the effect of estradiol on ER expression as well as on proteoglycan and metalloproteinase expression was studied. The effect of E2 on extracellular matrix molecule expression has been studied using ERα suppression in breast cancer cells. Our studies using ERα-positive MCF-7 cells show that estradiol affects the expression of syndecan-2, but not of syndecan-4, through ERα. Furthermore, the ability of estradiol to affect MMP-9 and TIMP-1 expression is connected with ERα status. Together, these data demonstrate the significant role of ERα on mediating the effect of estradiol on extracellular matrix molecules.

Keywords: Proteoglycans, Metalloproteinases, Tissue inhibitors of metalloproteinases, Estradiol, Breast cancer, Estrogen receptor α

Abbreviations: E2, estradiol, PG, proteoglycan, MMP, matrix metalloproteinase, TIMP, tissue inhibitor of metalloproteinase, ECM, extracellular matrix, ER, estrogen receptor, ERE, estrogen responsive element

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1574-7891(08)00072-0

doi:10.1016/j.molonc.2008.06.002

Molecular Oncology
Volume 2, Issue 3 , Pages 223-232, October 2008